Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Karuna Therapeutics Inc. (KRTX)

85.7   3.39 (4.12%) 02-26 16:00
Open: 82.81 Pre. Close: 82.31
High: 87.49 Low: 82.58
Volume: 296,507 Market Cap: 2229M
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer's, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeut

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 87.531 - 88.06 88.06 - 88.566
Low: 81.377 - 81.976 81.976 - 82.549
Close: 84.757 - 85.663 85.663 - 86.531

Technical analysis

as of: 2020-02-26 4:30:07 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 120.45     One year: 135.63
Support: Support1: 82.10    Support2: 68.31
Resistance: Resistance1: 103.12    Resistance2: 116.12
Pivot: 95.04
Moving Average: MA(5): 90.78     MA(20): 95.03
MA(100): 62.45     MA(250):
MACD: MACD(12,26): 0.34     Signal(9): 2.64
Stochastic oscillator: %K(14,3): 9.50     %D(3): 24.48
RSI: RSI(14): 43.46
52-week: High: 152.00  Low: 11.24  Change(%): 328.1
Average Vol(K): 3-Month: 52143  10-Days: 27403

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
KRTX has closed above bottom band by 5.6%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to KRTX's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2020-02-25
Karuna Therapeutics to Present at the Cowen and Company's 40th Annual Health Care Conference
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics, will present at the Cowen and Company's 40th Annual Health Care Conference being held at the Boston Marriott Cop

2020-02-06
Karuna Therapeutics Provides Update on its Discovery Research Efforts
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced an update on its research and development efforts in CNS. To accommodate continued growth in its drug discovery efforts, Karuna announced the opening of an office in Indianapolis, Indiana. Additionally, Karu

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 26.01
Shares Float (M) 13.82
% Held by Insiders 20.81
% Held by Institutions 55.24
Shares Short (K) 369
Shares Short P. Month (K)

Stock Financials

EPS -1.900
Book Value (p.s.) 6.940
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.716
Qtrly Earnings Growth
Operating Cash Flow (M) -30.97
Levered Free Cash Flow (M)

Stock Valuations

P/E -45.11
P/E Growth Ratio 0.04
P/BV 12.35
P/S
P/CF -71.97

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.